Pricing Log in Create free account
Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue
+38.3%
EPS
−294.7%
Free cash flow
+5.09%
Total debt
+40.8%

Quarter to June 2026, against a year earlier

25.12 1.06 +4.41%
Market cap
$5.6B
P/E
0.0×
Fwd P/E
−49.4×
Dividend yield
—
F-score
4/9
Altman Z
4.10
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Hims & Hers Health, Inc. (HIMS) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Hims & Hers Health, Inc. (HIMS) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from 0.0× (December 2020) to 11.9× (June 2021); the current reading is higher than 36% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.9× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.3× (1.65%)
FY2024 3.3× 61.56%
FY2023 2.1× (2.60%)
FY2022 2.1× (43.38%)
FY2022 3.7× 3.81%
FY2021 3.6× 18.10%
FY2021 3.1× 9.18%
FY2020 2.8× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 3.3× 58.49%
Mar 2026 2.1× (36.13%)
Dec 2025 3.3× (44.98%)
Sep 2025 6.0× 9.02%
22 more quarters

Against its own ten years

Low 0.0× High 11.9×
Ten-year median 2.8×
Current reading's percentile 22

EV/Sales against peers

Company EV/Sales
HIMS Hims & Hers Health, Inc. 2.4×
SUPN Indivior Pharmaceuticals Inc. compare 2.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 3.0×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
LNTH Lantheus Holdings, Inc. compare 4.1×
ALKS Alkermes plc compare 4.7×
KNSA Kiniksa Pharmaceuticals International, plc compare 6.7×
LQDA Liquidia Corporation compare 8.6×
AMLX Amylyx Pharmaceuticals, Inc. compare 32.5×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HIMS